Jonathan Michael Peterson

US Patent:

7673697, Mar 9, 2010

Filed:

Jan 23, 2002

Appl. No.:

10/056250

Inventors:

Jonathan Michael Peterson - Chisago City MN, US

International Classification:

A01B 45/00

US Classification:

172 19, 172 20, 2424225

Abstract:

A sod-laying machine having a low center of gravity and a seated operator position adjacent the roll of sod being placed. The superior visibility available to the operator makes it possible to place the sod more accurately and with less need for subsequent adjustment than has been possible previously. The machine has sod roll lifting arms that can be spaced apart to lift and place rolls having any of the common large sod roll widths. The machine can be configured to lay sod that is rolled with either the grass side or the dirt side outermost. Propulsion, roll lifting and roll width adjustment is hydraulic with continuously variable speed drive. Turf scuffing is minimized by trailing caster wheels and independently controllable drive wheels mounted close to the location of the sod roll.

US Patent:

20150099695, Apr 9, 2015

Filed:

May 28, 2013

Appl. No.:

14/403306

Inventors:

- Baltimore MD, US
Jonathan M. Peterson - Parkville MD, US

International Classification:

C07K 14/47
A61K 45/06
C12Q 1/68
A61K 38/17

US Classification:

514 48, 514 69, 514 212, 514 74, 435 612

Abstract:

Compositions and methods for treatment of obesity and/or Type II diabetes and related metabolic disorders are provided wherein the methods and treatments comprise an effective amount of an isolated and/or purified C1q/TNF-related Protein-9 (CTRP9) or a functional portion thereof, and a pharmaceutically acceptable carrier. Methods of screening for molecules which elevate levels of CTRP9 in vivo are also provided. The present inventors provide the first in vivo evidence linking CTRP9 to regulation of fat metabolism in liver and skeletal muscle via AMPK signaling pathway, and highlight its protective metabolic function in the context of HFD-mediated metabolic insults.

US Patent:

20140147421, May 29, 2014

Filed:

Apr 11, 2012

Appl. No.:

14/111003

Inventors:

Guang William Wong - Lutherville MD, US
Zhikui Wei - Baltimore MD, US
Jonathan M. Peterson - Parkville MD, US

International Classification:

C07K 14/47

US Classification:

424 937, 514 69, 530350, 536 235, 514 44 R, 435 612, 435 792

Abstract:

The present invention provides substantially purified peptide portions of adipokine polypeptides, including, for example, Clq/TNF-related protein-12 (CTRP12), a functional homologue or function fragment of CTRP12, and a fusion polypeptide comprising any of the above. Methods for treating Type 2 diabetes mellitus by administering to a patient any of the following; CTRP12, a functional homologue of CTRP12, a functional fragment of CTRP12 or its functional homologue, a fusion polypeptide comprising any of the above, a substantially purified nucleic acid molecule encoding a polypeptide of any of the above, a vector comprising such nucleic acid molecule, a host cell transformed with such vector, a ligand that specifically binds to a polypeptide mentioned above, a compound that modifies the level of expression or activity of the amino acid sequence according to any of the above, a pharmaceutical composition comprising any one the above and a pharmaceutically acceptable carrier, and any combination of the above are also provided.

Address:

8326 Wyoming Trl, Chisago City, MN 55013

VIN:

4UMTU18297M000073

Make:

Toyota

Model:

Tacoma XtraCab V6 Manual

Year:

2007